Bath ASU provides a complete range of aseptic manufacturing services including patient specific chemotherapy, dose banded batch chemotherapy, central intravenous additive service (civas), patient-controlled analgesia products (PCA) and total parenteral nutrition (TPN).
The company provides a readily accessible, flexible service, complementing existing provisions and assisting NHS Trusts and private hospitals in addressing their workload, costs and planning demands.
Bath ASU's services are tailored specifically to the needs of individual customers and their patients, and this flexibility enables customers to purchase products conforming to their specification rather than a specification that suits the supplier.
Bath ASU leads the industry in service and product innovations. The company's programme of continual improvement supports our drive to improve product quality and add value.
